|
시장보고서
상품코드
2055088
알레르기 주사 시장 : 질환 적응증별, 알레르기 유형별, 면역치료 유형별, 제제별, 연령층별, 성별, 최종 사용자별, 유통 채널별, 지역별Allergy Shots Market, By Disease Indication, By Allergen Type, By Immunotherapy Type, By Formulation, By Age Group, By Gender, By End User, By Distribution Channel, By Geography |
||||||
알레르기 주사 시장은 2026년에 58억 9,000만 달러에 달하고 2033년까지 92억 7,000만 달러에 이를 전망입니다. 2026-2033년 CAGR은 6.7%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 58억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 6.70% | 시장 규모 예측(2033년) : | 92억 7,000만 달러 |
세계 알레르기 주사 시장은 광범위한 면역요법 분야에서 중요한 치료 부문을 차지하고 있으며, 전 세계적으로 증가하는 알레르기 질환에 대응하는 역할을 담당하고 있습니다. 알레르기 주사는 알레르기 면역요법 또는 피하 면역요법(SCIT)이라고도 불리며, 특정 알레르기의 용량을 서서히 늘려 투여함으로써 환자의 감작을 줄이고 과민한 면역 반응을 억제하는 치료법입니다.
이 치료법은 계절성 알레르기, 집먼지진드기 알레르기, 반려동물 비듬에 대한 과민증, 곤충 독 알레르기 등 다양한 알레르기 질환에 대한 장기적인 해결책으로 큰 주목을 받고 있습니다. 이 시장에는 알레르기 증상을 지속적으로 완화하도록 설계된 다양한 알레르기 추출물, 표준화 백신 및 특수 투여 시스템이 포함되어 있습니다. 도시화, 환경 오염, 생활 방식의 변화와 같은 요인으로 인해 전 세계적으로 알레르기 질환의 부담이 커지는 가운데, 효과적인 면역 요법 솔루션에 대한 수요는 계속해서 증가하고 있습니다. 의료진과 환자 모두 알레르기 주사가 단순한 증상 관리에 그치지 않고 근본적인 원인을 해결하는 질환 수정 치료로서의 가치를 인식하고 있으며, 이 시장은 향후 몇 년 동안 큰 성장이 예상됩니다.
시장 역학
세계 알레르기 주사 시장은 현대 의료 분야에서 그 중요성이 커지고 있음을 뒷받침하는 몇 가지 주요 시장 성장 촉진요인에 힘입어 성장하고 있습니다. 주요 성장 요인은 전 세계 알레르기 질환 유병률 증가입니다. 연구에 따르면, 알레르기 질환은 전 세계 인구의 약 25%에 영향을 미치고 있으며, 효과적인 치료법이 필요한 방대한 환자층을 형성하고 있습니다. 증상 완화 치료에 비해 면역 요법의 장기적인 이점에 대한 인식이 높아짐에 따라, 의료진과 환자 모두 알레르기 주사를 우선적인 치료법으로 채택하도록 장려하고 있습니다. 또한, 알레르기의 표준화 및 정제 기술의 발전으로 인해 알레르기 주사의 안전성과 유효성이 향상되어, 의사의 신뢰와 환자의 수용도가 높아지고 있습니다.
맞춤형 의료에 대한 관심이 높아지고 있는 점도 시장 성장에 기여하고 있습니다. 알레르기 주사는 개개인의 알레르기 유발 물질 프로파일에 맞추어 조절할 수 있기 때문입니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 예를 들어, 치료 기간이 보통 3-5년으로 길기 때문에 환자의 치료 순응도나 치료 지속에 지장을 줄 수 있습니다. 아나필락시스를 포함한 심각한 알레르기 반응의 위험이 있으므로, 신중한 모니터링과 전문적인 의료 환경이 필요하며, 특정 지역에서는 이용이 제한되고 있습니다. 개발도상국 시장의 높은 치료비와 불충분한 보험 적용 범위 또한 보급을 가로막는 또 다른 장애물이 되고 있습니다. 이러한 과제가 존재하지만, 헬스케어 인프라가 점차 정비되고 알레르기 질환에 대한 인식이 높아지고 있는 신흥 시장에는 큰 기회가 존재합니다. 설하 면역요법이나 경피 패치와 같은 새로운 투여 시스템의 개발은 시장 확대의 기회를 제공합니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 세계 알레르기 주사 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로는 기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적 및 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 알레르기 주사 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 알레르기 주사 시장을 분석하는 데 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 알레르기 주사 시장 : 질환 적응증별(2021-2033년)
제5장 세계의 알레르기 주사 시장 : 알레르기 유형별(2021-2033년)
제6장 세계의 알레르기 주사 시장 : 면역치료 유형별(2021-2033년)
제7장 세계의 알레르기 주사 시장 : 제제별(2021-2033년)
제8장 세계의 알레르기 주사 시장 : 연령층별(2021-2033년)
제9장 세계의 알레르기 주사 시장 : 성별(2021-2033년)
제10장 세계의 알레르기 주사 시장 : 최종 사용자별(2021-2033년)
제11장 세계의 알레르기 주사 시장 : 유통 채널별(2021-2033년)
제12장 세계의 알레르기 주사 시장 : 지역별(2021-2033년)
제13장 경쟁 구도
제14장 애널리스트의 제안
제15장 참고 문헌 및 조사 방법
KTH 26.06.19Allergy Shots Market is estimated to be valued at USD 5.89 Bn in 2026 and is expected to reach USD 9.27 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 5.89 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 6.70% | 2033 Value Projection: | USD 9.27 Bn |
The global allergy shots market represents a critical therapeutic segment within the broader immunotherapy landscape, addressing the growing prevalence of allergic conditions worldwide. Allergy shots, also known as allergen immunotherapy or subcutaneous immunotherapy (SCIT), involve the administration of gradually increasing doses of specific allergens to desensitize patients and reduce their hypersensitive immune responses.
This treatment modality has gained significant traction as a long-term solution for various allergic conditions, including seasonal allergies, dust mite allergies, pet dander sensitivities, and insect venom allergies. The market encompasses a diverse range of allergen extracts, standardized vaccines, and specialized delivery systems designed to provide sustained relief from allergic symptoms. With the increasing burden of allergic diseases globally, driven by factors such as urbanization, environmental pollution, and changing lifestyle patterns, the demand for effective immunotherapy solutions continues to rise. Healthcare providers and patients alike are recognizing the value of allergy shots as a disease-modifying treatment that addresses root causes rather than merely managing symptoms, positioning this market for substantial growth in the coming years.
Market Dynamics
The global allergy shots market is propelled by several key drivers that underscore its expanding significance in modern healthcare. The primary growth driver is the escalating prevalence of allergic conditions worldwide, with studies indicating that allergic diseases affect approximately 25% of the global population, creating a substantial patient base requiring effective treatment solutions. Rising awareness about the long-term benefits of immunotherapy over symptomatic treatments has encouraged both healthcare providers and patients to adopt allergy shots as a preferred therapeutic approach. Additionally, advancements in allergen standardization and purification technologies have enhanced the safety and efficacy profiles of allergy shots, boosting physician confidence and patient acceptance.
The growing emphasis on personalized medicine has also contributed to market growth, as allergy shots can be tailored to individual allergen profiles. However, the market faces notable restraints including the lengthy treatment duration typically spanning 3-5 years, which may deter patient compliance and adherence. The risk of severe allergic reactions, including anaphylaxis, requires careful monitoring and specialized healthcare settings, limiting accessibility in certain regions. High treatment costs and inadequate insurance coverage in developing markets pose additional barriers to widespread adoption. Despite these challenges, significant opportunities exist in emerging markets where healthcare infrastructure is improving and awareness of allergic diseases is increasing. The development of novel delivery systems, such as sublingual immunotherapy and epicutaneous patches, presents opportunities for market expansion.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global allergy shots market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include ALK-Abello A/S, HAL Allergy B.V.,, Stallergenes Greer, AllVac Pharmaceuticals, Allergopharma (Merck KGaA), Roche, Biomay AG, LETIPharma, Inmunotek S.L., Allergy Therapeutics, Astellas Pharma Inc., DBV Technologies, Anergis SA, and Circassia Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global allergy shots market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergy shots market
Market Segmentation
- Disease Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Allergic Rhinitis
- Allergic Asthma
- Atopic Dermatitis (Eczema)
- Venom Hypersensitivity
- Allergic Conjunctivitis
- Chronic Sinusitis with Nasal Polyps
- Allergen Type Insights (Revenue, USD Bn, 2021 - 2033)
- Pollen
- Dust Mites
- Mold
- Animal Dander
- Insect Venom
- Other Food Allergens
- Immunotherapy Type Insights (Revenue, USD Bn, 2021 - 2033)
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
- Epicutaneous Immunotherapy (EPIT)
- Oral Immunotherapy (OIT)
- Intralymphatic Immunotherapy (ILIT)
- Formulation Insights (Revenue, USD Bn, 2021 - 2033)
- Injectable Suspensions
- Drops
- Tablets
- Capsules
- Transdermal Patches
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adults
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Female
- Male
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Allergy and Immunology Specialty Clinics
- Homecare Settings
- Others (Research and Academic Institutions, etc.)
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Oline Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- ALK-Abello A/S
- HAL Allergy B.V.,
- Stallergenes Greer
- AllVac Pharmaceuticals
- Allergopharma (Merck KGaA)
- Roche
- Biomay AG
- LETIPharma
- Inmunotek S.L.
- Allergy Therapeutics
- Astellas Pharma Inc.
- DBV Technologies
- Anergis SA
- Circassia Pharmaceuticals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Allergy Shots Market, By Disease Indication
- Global Allergy Shots Market, By Allergen Type
- Global Allergy Shots Market, By Immunotherapy Type
- Global Allergy Shots Market, By Formulation
- Global Allergy Shots Market, By Age Group
- Global Allergy Shots Market, By Gender
- Global Allergy Shots Market, By End User
- Global Allergy Shots Market, By Distribution Channel
- Global Allergy Shots Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Allergy Shots Market, By Disease Indication, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Allergic Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Atopic Dermatitis (Eczema)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Venom Hypersensitivity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Allergic Conjunctivitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Chronic Sinusitis with Nasal Polyps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Allergy Shots Market, By Allergen Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pollen
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Dust Mites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Mold
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Animal Dander
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Insect Venom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Food Allergens
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Allergy Shots Market, By Immunotherapy Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Subcutaneous Immunotherapy (SCIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Sublingual Immunotherapy (SLIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Epicutaneous Immunotherapy (EPIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oral Immunotherapy (OIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Intralymphatic Immunotherapy (ILIT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Allergy Shots Market, By Formulation, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Injectable Suspensions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Drops
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Transdermal Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Allergy Shots Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Allergy Shots Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Allergy Shots Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Allergy and Immunology Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Research and Academic Institutions, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Allergy Shots Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Oline Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
12. Global Allergy Shots Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Allergen Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Immunotherapy Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Formulation, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive Landscape
- ALK-Abello A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HAL Allergy B.V.,
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Stallergenes Greer
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AllVac Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergopharma (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biomay AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- LETIPharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inmunotek S.L.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Allergy Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DBV Technologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Anergis SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Circassia Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
